Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philippine Ebola outbreak prompts precautions

This article was originally published in Scrip

Executive Summary

The first reported cases of the Ebola virus in swine are creating health concerns in the Philippines, where the World Health Organizationis recommending precautions against possible human transmission. The Reston species – which is also referred to as Asian filovirus, was identified in 1989 when infected crab-eating macaques were exported from the Philippines to Hazelton Laboratores in Reston, Virginia. Ebola Reston has previously only infected monkeys, and has not been known to infect humans. The virus was detected in pigs in the Philippines in December, and it is of concern because pigs are food-producing animals for humans. Other strains of the haemorrhagic virus, such as Ebola Zaire and Ebola Sudan, are highly infectious and can have a human fatality rate of up to 90%. The WHO, World Organization for Animal Health and UN Food and Agriculture Organization are working with local authorities to investigate virulence and transmission routes. There are no available vaccines against any strain of the Ebola virus.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC008070

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel